Artificial Sweeteners May Disrupt Metabolism and Gut Health
A recent study suggests that artificial or non-caloric sweeteners may affect the body in unexpected ways, with new evidence pointing to a link between their consumption and changes in metabolism and gut health. Researchers from the Food is Medicine Institute at Tufts University conducted a review of 21 randomised clinical trials in adults and performed a meta-analysis to assess the impact of non-nutritive sweeteners on cardiometabolic health. The study encompassed various types of low-calorie sweeteners commonly found in diet drinks, sugar-free chewing gum, and protein bars. “What makes our analysis stand out is that by focusing on a non-caloric comparator, we were able to isolate the direct physiological effects of the sweeteners themselves, rather than the calories they replace,” said Meng Wang, a research assistant professor at the institute and the study’s lead author. The findings challenge the long-standing assumption that artificial sweeteners are metabolically inert, merely passing through the body without affecting biological processes. When compared against non-caloric controls such as water or a placebo, sweetener consumption was associated with higher fasting insulin levels and an increase in HbA1c, a marker of long-term blood sugar control. The analysis also found a trend towards worsening insulin sensitivity. Bryan Quoc Le, a food scientist and author of 150 Food Science Questions Answered, provided an important caveat. Despite these findings, the benefits of reducing sugar intake should not be overlooked. “We know that long-term high sugar consumption causes many chronic conditions, so the benefits of replacing sugar are known and well-established,” he explained. One potential explanation for these effects involves the gut microbiome, the community of microbes in the digestive tract that plays a crucial role in immunity and metabolic health. Artificial sweeteners typically pass through the gut and come into direct contact with these microorganisms. The review showed evidence that certain low-calorie sweeteners alter the composition and function of gut bacteria. The researchers used detailed microbiome profiling and microbial transfer experiments from humans to mice to identify these changes. However, Le stressed that whether these microbiome changes truly impact long-term health outcomes remains a subject of debate. “This is still under discussion, especially given the complexity of the gut microbiome, inter-individual variation, and the different types of sweeteners at varying concentrations over time,” he added. Experts caution that the category of non-nutritive sweeteners is very broad, encompassing synthetic products like aspartame, saccharin, and acesulfame potassium, as well as natural alternatives like stevia and monk fruit. The researchers noted that each type of sweetener may have distinct biological effects, meaning some might be more problematic than others. In addition to clinical trials, the authors also reviewed large observational population studies that found an association between non-nutritive sweeteners and a higher risk of cardiometabolic disease. However, observational studies cannot prove causation, as it is possible that people already at high risk for these diseases are more likely to choose low-calorie sweeteners.